John M. Centanni
Consigliere Generale presso COYA THERAPEUTICS, INC.
Profilo
John M.
Centanni is Manager of Regulatory Affairs and Quality Assurance and Senior Scientist of Stratatech Corp.
He joined Stratatech in 2001.
He was a Researcher at the NCI- Frederick Cancer Research Center.
Mr. Centanni received an MS degree in Biomedical Sciences.
Posizioni attive di John M. Centanni
Società | Posizione | Inizio |
---|---|---|
COYA THERAPEUTICS, INC. | Consigliere Generale | 01/03/2022 |
Precedenti posizioni note di John M. Centanni
Società | Posizione | Fine |
---|---|---|
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Consigliere Generale | - |
Stratatech Corp.
Stratatech Corp. Miscellaneous Commercial ServicesCommercial Services Stratatech Corp. develops and provides genetically enhanced tissues. The firm focuses on skin regeneration therapies for severe burns and other rare diseases, as well as chronic non-healing ulcers. The company was founded by B. Lynn Allen-Hoffmann in 2000 and is headquartered in Madison, WI. | Consigliere Generale | - |
Formazione di John M. Centanni
Hood College | Graduate Degree |
University of Wisconsin Oshkosh | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
COYA THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Stratatech Corp.
Stratatech Corp. Miscellaneous Commercial ServicesCommercial Services Stratatech Corp. develops and provides genetically enhanced tissues. The firm focuses on skin regeneration therapies for severe burns and other rare diseases, as well as chronic non-healing ulcers. The company was founded by B. Lynn Allen-Hoffmann in 2000 and is headquartered in Madison, WI. | Commercial Services |
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- John M. Centanni